TreeWAS – Variant ID: rs9579199

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H57 Other disorders of eye and adnexa	0.051	0.949	0.000
H57.9 Disorder of eye and adnexa, unspecified	0.050	0.950	0.000
H57.1 Ocular pain	0.047	0.953	0.000
H57.8 Other specified disorders of eye and adnexa	0.045	0.955	0.000
H55 Nystagmus and other irregular eye movements	0.045	0.955	0.000
H55-H59 Other disorders of eye and adnexa	0.045	0.955	0.000
Z88.6 Personal history of allergy to analgesic agent	0.035	0.965	0.000
H57.0 Anomalies of pupillary function	0.035	0.965	0.000
H58 Other disorders of eye and adnexa in diseases classified elsewhere	0.035	0.965	0.000
H59 Postprocedural disorders of eye and adnexa, not elsewhere classified	0.033	0.967	0.000
H59.8 Other postprocedural disorders of eye and adnexa	0.028	0.972	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.027	0.973	0.000
H58.9 Other specified disorders of eye and adnexa in diseases classified elsewhere	0.025	0.975	0.000
H58.1 Visual disturbances in diseases classified elsewhere	0.025	0.975	0.000
H58.0 Anomalies of pupillary function in diseases classified elsewhere	0.025	0.975	0.000
H59.0 Vitreous syndrome following cataract surgery	0.024	0.976	0.000
H59.9 Postprocedural disorder of eye and adnexa, unspecified	0.018	0.982	0.000
F05.9 Delirium, unspecified	0.015	0.985	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.990	0.010
F05 Delirium, not induced by alcohol and other psychoactive substances	0.009	0.991	0.000
F05.1 Delirium superimposed on dementia	0.007	0.993	0.000
F05.0 Delirium not superimposed on dementia, so described	0.007	0.993	0.000
F05.8 Other delirium	0.007	0.993	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.994	0.006
F31.3 Bipolar affective disorder, current episode mild or moderate depression	0.006	0.994	0.000
F31 Bipolar affective disorder	0.006	0.994	0.000
F31.0 Bipolar affective disorder, current episode hypomanic	0.006	0.994	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.994	0.006
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.994	0.006
T90.2 Sequelae of fracture of skull and facial bones	0.006	0.994	0.000
F31.6 Bipolar affective disorder, current episode mixed	0.006	0.994	0.000
T39.1 4-Aminophenol derivatives	0.000	0.994	0.006
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.995	0.005
F31.5 Bipolar affective disorder, current episode severe depression with psychotic symptoms	0.005	0.995	0.000
F31.8 Other bipolar affective disorders	0.005	0.995	0.000
F31.1 Bipolar affective disorder, current episode manic without psychotic symptoms	0.005	0.995	0.000
R40.2 Coma, unspecified	0.000	0.995	0.005
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.005	0.995	0.000
H18.5 Hereditary corneal dystrophies	0.005	0.995	0.000
F31.9 Bipolar affective disorder, unspecified	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
T36 Poisoning by systemic antibiotics	0.000	0.995	0.005
Z74.0 Reduced mobility	0.000	0.995	0.005
F31.7 Bipolar affective disorder, currently in remission	0.004	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.995	0.004
T50.5 Appetite depressants	0.000	0.995	0.004
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.995	0.004
T50.0 Mineralocorticoids and their antagonists	0.000	0.995	0.004
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.995	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.995	0.005
T50.8 Diagnostic agents	0.000	0.995	0.004
K86.3 Pseudocyst of pancreas	0.005	0.995	0.000
F31.4 Bipolar affective disorder, current episode severe depression without psychotic symptoms	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
T36.0 Penicillins	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.996	0.004
T45.5 Anticoagulants	0.000	0.996	0.004
T40.2 Other opioids	0.000	0.996	0.004
T39.4 Antirheumatics, not elsewhere classified	0.000	0.996	0.004
T39.2 Pyrazolone derivatives	0.000	0.996	0.004
E55.9 Vitamin D deficiency, unspecified	0.000	0.996	0.004
I07.1 Tricuspid insufficiency	0.004	0.996	0.000
H18 Other disorders of cornea	0.004	0.996	0.000
T50.1 Loop [high-ceiling] diuretics	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
T36.8 Other systemic antibiotics	0.000	0.996	0.004
H25.1 Senile nuclear cataract	0.004	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.996	0.004
I21.2 Acute transmural myocardial infarction of other sites	0.004	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.996	0.004
T40.4 Other synthetic narcotics	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.004
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.004
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.996	0.004
Z97.5 Presence of (intra-uterine) contraceptive device	0.004	0.996	0.000
C16.9 Stomach, unspecified	0.000	0.996	0.004
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.996	0.004
T36.4 Tetracyclines	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.003
T36.9 Systemic antibiotic, unspecified	0.000	0.996	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.996	0.003
T36.6 Rifamycins	0.000	0.996	0.003
T36.5 Aminoglycosides	0.000	0.996	0.003
T36.2 Chloramphenicol group	0.000	0.996	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.996	0.003
T45.4 Iron and its compounds	0.000	0.996	0.003
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.003
H18.9 Disorder of cornea, unspecified	0.003	0.996	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.003
T36.3 Macrolides	0.000	0.997	0.003
H18.3 Changes in corneal membranes	0.003	0.997	0.000
J34.8 Other specified disorders of nose and nasal sinuses	0.003	0.997	0.000
H18.0 Corneal pigmentations and deposits	0.003	0.997	0.000
H18.7 Other corneal deformities	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
T46.1 Calcium-channel blockers	0.000	0.997	0.003
H18.6 Keratoconus	0.003	0.997	0.000
T40.1 Heroin	0.000	0.997	0.003
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
H18.1 Bullous keratopathy	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.003
H18.8 Other specified disorders of cornea	0.003	0.997	0.000
T40.3 Methadone	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
T39.0 Salicylates	0.000	0.997	0.003
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.997	0.003
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.003
H18.4 Corneal degeneration	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.003
T46.7 Peripheral vasodilators	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.003
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.997	0.003
W55.0 Home	0.000	0.997	0.003
S52.80 Fracture of other parts of forearm (closed)	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
H11.9 Disorder of conjunctiva, unspecified	0.000	0.997	0.003
M06.0 Seronegative rheumatoid arthritis	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T90 Sequelae of injuries of head	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.997	0.003
I21.4 Acute subendocardial myocardial infarction	0.000	0.997	0.003
T42.4 Benzodiazepines	0.000	0.997	0.003
Q61.0 Congenital single renal cyst	0.000	0.997	0.003
T90.4 Sequelae of injury of eye and orbit	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
K70.3 Alcoholic cirrhosis of liver	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.002
H18.2 Other corneal oedema	0.003	0.997	0.000
C16.2 Body of stomach	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.002
M79.67 Pain in limb (Ankle and foot)	0.000	0.997	0.003
F11.2 Dependence syndrome	0.003	0.997	0.000
H17.8 Other corneal scars and opacities	0.003	0.997	0.000
H81.0 Meniere's disease	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.002
T18.1 Foreign body in oesophagus	0.000	0.997	0.003
T90.8 Sequelae of other specified injuries of head	0.003	0.997	0.000
D35.0 Adrenal gland	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.002
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.002
T47.7 Emetics	0.000	0.997	0.002
T47.5 Digestants	0.000	0.997	0.002
T47.3 Saline and osmotic laxatives	0.000	0.997	0.002
T47.2 Stimulant laxatives	0.000	0.997	0.002
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.002
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.002
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.997	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.002
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.002
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.002
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.998	0.002
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
H17 Corneal scars and opacities	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
T93.8 Sequelae of other specified injuries of lower limb	0.000	0.998	0.002
T93 Sequelae of injuries of lower limb	0.000	0.998	0.002
H15-H22 Disorders of sclera, cornea, iris and ciliary body	0.002	0.998	0.000
H53.1 Subjective visual disturbances	0.000	0.998	0.002
T42.3 Barbiturates	0.000	0.998	0.002
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
T42.1 Iminostilbenes	0.000	0.998	0.002
M54.39 Sciatica (Site unspecified)	0.002	0.998	0.000
N95.0 Postmenopausal bleeding	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.000	0.998	0.002
T93.1 Sequelae of fracture of femur	0.000	0.998	0.002
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.998	0.002
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
C16 Malignant neoplasm of stomach	0.000	0.998	0.002
N42.1 Congestion and haemorrhage of prostate	0.002	0.998	0.000
I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified	0.000	0.998	0.002
H22 Disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
C21.1 Anal canal	0.000	0.998	0.002
E55 Vitamin D deficiency	0.000	0.998	0.002
C16.4 Pylorus	0.000	0.998	0.002
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
X51.9 Unspecified place	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.998	0.002
H22.1 Iridocyclitis in other diseases classified elsewhere	0.002	0.998	0.000
S62.30 Fracture of other metacarpal bone (closed)	0.000	0.998	0.002
H21.0 Hyphaema	0.002	0.998	0.000
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.998	0.002
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
T90.3 Sequelae of injury of cranial nerves	0.002	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.002	0.998	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.998	0.002
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
T47.4 Other laxatives	0.000	0.998	0.002
Z95.4 Presence of other heart-valve replacement	0.000	0.998	0.002
H35.4 Peripheral retinal degeneration	0.002	0.998	0.000
S52.20 Fracture of shaft of ulna (closed)	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
Z90.5 Acquired absence of kidney	0.002	0.998	0.000
C16.6 Greater curvature of stomach, unspecified	0.000	0.998	0.002
K22.7 Barrett's oesophagus	0.002	0.998	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.002	0.998	0.000
L53.9 Erythematous condition, unspecified	0.000	0.998	0.002
T93.9 Sequelae of unspecified injury of lower limb	0.000	0.998	0.002
T93.0 Sequelae of open wound of lower limb	0.000	0.998	0.002
C16.3 Pyloric antrum	0.000	0.998	0.002
C16.1 Fundus of stomach	0.000	0.998	0.002
H17.1 Other central corneal opacity	0.002	0.998	0.000
H17.0 Adherent leukoma	0.002	0.998	0.000
T93.4 Sequelae of injury of nerve of lower limb	0.000	0.998	0.002
H66.3 Other chronic suppurative otitis media	0.002	0.998	0.000
T17.2 Foreign body in pharynx	0.000	0.998	0.002
T90.9 Sequelae of unspecified injury of head	0.002	0.998	0.000
M80.98 Unspecified osteoporosis with pathological fracture (Other)	0.000	0.998	0.002
H11.2 Conjunctival scars	0.000	0.998	0.002
T93.6 Sequelae of crushing injury and traumatic amputation of lower limb	0.000	0.998	0.002
I07 Rheumatic tricuspid valve diseases	0.002	0.998	0.000
H69.9 Eustachian tube disorder, unspecified	0.002	0.998	0.000
S82.40 Fracture of fibula alone (closed)	0.000	0.998	0.002
E55.0 Rickets, active	0.000	0.998	0.002
H22.8 Other disorders of iris and ciliary body in diseases classified elsewhere	0.002	0.998	0.000
H22.0 Iridocyclitis in infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
N90.8 Other specified noninflammatory disorders of vulva and perineum	0.000	0.998	0.002
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.998	0.002
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
T43.6 Psychostimulants with abuse potential	0.000	0.998	0.002
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.998	0.002
T93.2 Sequelae of other fractures of lower limb	0.000	0.998	0.002
T18 Foreign body in alimentary tract	0.000	0.998	0.002
R49.8 Other and unspecified voice disturbances	0.000	0.998	0.002
T38.9 Other and unspecified hormone antagonists	0.000	0.998	0.001
T38.7 Androgens and anabolic congeners	0.000	0.998	0.001
T38.4 Oral contraceptives	0.000	0.998	0.001
T38.2 Antithyroid drugs	0.000	0.998	0.001
T38.0 Glucocorticoids and synthetic analogues	0.000	0.998	0.001
C71.9 Brain, unspecified	0.002	0.998	0.000
D35.1 Parathyroid gland	0.000	0.998	0.002
H11.1 Conjunctival degenerations and deposits	0.000	0.998	0.002
H47.1 Papilloedema, unspecified	0.000	0.998	0.002
T90.1 Sequelae of open wound of head	0.002	0.998	0.000
F12.1 Harmful use	0.002	0.998	0.000
H17.9 Corneal scar and opacity, unspecified	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.998	0.002
H11 Other disorders of conjunctiva	0.000	0.998	0.002
W55 Bitten or struck by other mammals	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.998	0.001
C16.8 Overlapping lesion of stomach	0.000	0.998	0.002
H21.1 Other vascular disorders of iris and ciliary body	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.001	0.998	0.001
H11.8 Other specified disorders of conjunctiva	0.000	0.998	0.002
T38.5 Other oestrogens and progestogens	0.001	0.998	0.001
F11 Mental and behavioural disorders due to use of opioids	0.002	0.998	0.000
C71.3 Parietal lobe	0.002	0.998	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.002	0.998	0.000
H21.3 Cyst of iris, ciliary body and anterior chamber	0.002	0.998	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.000	0.998	0.002
T38.1 Thyroid hormones and substitutes	0.000	0.998	0.001
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.998	0.002
T17 Foreign body in respiratory tract	0.000	0.998	0.002
S12.10 Fracture of second cervical vertebra (closed)	0.000	0.998	0.002
H21.2 Degeneration of iris and ciliary body	0.002	0.998	0.000
T17.3 Foreign body in larynx	0.000	0.998	0.002
T18.5 Foreign body in anus and rectum	0.000	0.998	0.002
T93.5 Sequelae of injury of muscle and tendon of lower limb	0.000	0.998	0.002
H20 Iridocyclitis	0.002	0.998	0.000
G55.3 Nerve root and plexus compressions in other dorsopathies	0.002	0.998	0.000
H19.1 Herpesviral keratitis and keratoconjunctivitis	0.002	0.998	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.002	0.998	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.998	0.002
R53 Malaise and fatigue	0.000	0.998	0.002
F30.2 Mania with psychotic symptoms	0.002	0.998	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.998	0.002
H15 Disorders of sclera	0.002	0.998	0.000
H21.9 Disorder of iris and ciliary body, unspecified	0.002	0.998	0.000
H21.4 Pupillary membranes	0.002	0.998	0.000
S52.8 Fracture of other parts of forearm	0.002	0.998	0.000
T17.8 Foreign body in other and multiple parts of respiratory tract	0.000	0.998	0.002
T18.3 Foreign body in small intestine	0.000	0.998	0.002
W55.8 Other specified place	0.000	0.998	0.002
H47.3 Other disorders of optic disk	0.000	0.998	0.002
I07.9 Tricuspid valve disease, unspecified	0.002	0.998	0.000
I07.8 Other tricuspid valve diseases	0.002	0.998	0.000
I07.2 Tricuspid stenosis with insufficiency	0.002	0.998	0.000
I07.0 Tricuspid stenosis	0.002	0.998	0.000
F11.1 Harmful use	0.002	0.998	0.000
H21.5 Other adhesions and disruptions of iris and ciliary body	0.002	0.998	0.000
R85.5 Abnormal microbiological findings	0.000	0.998	0.002
T18.0 Foreign body in mouth	0.000	0.998	0.002
F06.7 Mild cognitive disorder	0.002	0.998	0.000
T18.8 Foreign body in other and multiple parts of alimentary tract	0.000	0.998	0.002
T18.4 Foreign body in colon	0.000	0.998	0.002
W60.0 Home	0.000	0.998	0.002
H47.2 Optic atrophy	0.000	0.998	0.002
X50.4 Street and highway	0.002	0.998	0.000
H46 Optic neuritis	0.000	0.998	0.002
H66 Suppurative and unspecified otitis media	0.002	0.998	0.000
H81.3 Other peripheral vertigo	0.000	0.998	0.002
W55.9 Unspecified place	0.000	0.998	0.001
W55.5 Trade and service area	0.000	0.998	0.001
W55.6 Industrial and construction area	0.000	0.998	0.001
W55.3 Sports and athletics area	0.000	0.998	0.001
W55.2 School, other institution and public administrative area	0.000	0.998	0.001
W55.1 Residential institution	0.000	0.998	0.001
H81 Disorders of vestibular function	0.000	0.998	0.002
X51 Travel and motion	0.002	0.998	0.000
F11.3 Withdrawal state	0.001	0.998	0.000
H15.9 Disorder of sclera, unspecified	0.001	0.998	0.000
H20.9 Iridocyclitis, unspecified	0.002	0.998	0.000
H66.4 Suppurative otitis media, unspecified	0.002	0.998	0.000
T17.5 Foreign body in bronchus	0.000	0.998	0.002
T18.2 Foreign body in stomach	0.000	0.998	0.001
H47 Other disorders of optic [2nd] nerve and visual pathways	0.000	0.998	0.002
H20.1 Chronic iridocyclitis	0.002	0.998	0.000
Z95.3 Presence of xenogenic heart valve	0.000	0.998	0.002
D35 Benign neoplasm of other and unspecified endocrine glands	0.000	0.998	0.002
F11.9 Unspecified mental and behavioural disorder	0.001	0.998	0.000
F11.8 Other mental and behavioural disorders	0.001	0.998	0.000
F11.7 Residual and late-onset psychotic disorder	0.001	0.998	0.000
F11.6 Amnesic syndrome	0.001	0.998	0.000
F11.5 Psychotic disorder	0.001	0.998	0.000
F11.4 Withdrawal state with delirium	0.001	0.998	0.000
F12.2 Dependence syndrome	0.002	0.998	0.000
H66.9 Otitis media, unspecified	0.002	0.998	0.000
H81.2 Vestibular neuronitis	0.000	0.998	0.002
T83.0 Mechanical complication of urinary (indwelling) catheter	0.002	0.998	0.000
D23.6 Skin of upper limb, including shoulder	0.002	0.998	0.000
T17.4 Foreign body in trachea	0.000	0.998	0.001
T17.1 Foreign body in nostril	0.000	0.998	0.001
T17.0 Foreign body in nasal sinus	0.000	0.998	0.001
F12 Mental and behavioural disorders due to use of cannabinoids	0.002	0.998	0.000
H16 Keratitis	0.002	0.998	0.000
F19.1 Harmful use	0.001	0.998	0.000
H20.2 Lens-induced iridocyclitis	0.001	0.998	0.000
C16.5 Lesser curvature of stomach, unspecified	0.000	0.998	0.001
Z74 Problems related to care-provider dependency	0.000	0.998	0.002
D11.0 Parotid gland	0.002	0.998	0.000
H15.0 Scleritis	0.001	0.998	0.000
W55.7 Farm	0.000	0.998	0.001
W55.4 Street and highway	0.000	0.998	0.001
Z97.2 Presence of dental prosthetic device (complete)(partial)	0.001	0.998	0.000
S32.30 Fracture of ilium (closed)	0.000	0.998	0.001
T16 Foreign body in ear	0.000	0.998	0.001
F00-F09 Organic, including symptomatic, mental disorders	0.002	0.998	0.000
L53 Other erythematous conditions	0.000	0.998	0.001
M79.60 Pain in limb (Multiple sites)	0.000	0.999	0.001
C71.0 Cerebrum, except lobes and ventricles	0.001	0.999	0.000
K35.3 Acute appendicitis with localized peritonitis	0.000	0.999	0.001
H16.8 Other keratitis	0.001	0.999	0.000
L53.8 Other specified erythematous conditions	0.000	0.999	0.001
S52.2 Fracture of shaft of ulna	0.001	0.999	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.001	0.999	0.001
W55.58 Bitten or struck by other mammals; Trade and service area;While engaged in other specified activities	0.000	0.999	0.001
W55.99 Bitten or struck by other mammals: Unspecified place: During unspecified activity	0.000	0.999	0.001
C71.7 Brain stem	0.001	0.999	0.000
H66.2 Chronic atticoantral suppurative otitis media	0.001	0.999	0.000
H66.0 Acute suppurative otitis media	0.001	0.999	0.000
X51.7 Farm	0.001	0.999	0.000
X51.6 Industrial and construction area	0.001	0.999	0.000
X51.5 Trade and service area	0.001	0.999	0.000
X51.4 Street and highway	0.001	0.999	0.000
X51.3 Sports and athletics area	0.001	0.999	0.000
X51.2 School, other institution and public administrative area	0.001	0.999	0.000
X51.1 Residential institution	0.001	0.999	0.000
X51.0 Home	0.001	0.999	0.000
F12.0 Acute intoxication	0.001	0.999	0.000
H47.7 Disorder of visual pathways, unspecified	0.000	0.999	0.001
H47.6 Disorders of visual cortex	0.000	0.999	0.001
H47.4 Disorders of optic chiasm	0.000	0.999	0.001
C71 Malignant neoplasm of brain	0.001	0.999	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.001	0.999	0.000
X50 Overexertion and strenuous or repetitive movements	0.001	0.999	0.000
T15-T19 Effects of foreign body entering through natural orifice	0.000	0.999	0.001
S52.81 Fracture of other parts of forearm (open)	0.001	0.999	0.000
D35.9 Endocrine gland, unspecified	0.000	0.999	0.001
D35.8 Pluriglandular involvement	0.000	0.999	0.001
D35.7 Other specified endocrine glands	0.000	0.999	0.001
D35.6 Aortic body and other paraganglia	0.000	0.999	0.001
D35.5 Carotid body	0.000	0.999	0.001
D35.4 Pineal gland	0.000	0.999	0.001
D35.3 Craniopharyngeal duct	0.000	0.999	0.001
F11.0 Acute intoxication	0.001	0.999	0.000
H16.4 Corneal neovascularisation	0.001	0.999	0.000
H16.3 Interstitial and deep keratitis	0.001	0.999	0.000
H21.8 Other specified disorders of iris and ciliary body	0.001	0.999	0.000
H53.4 Visual field defects	0.001	0.999	0.000
J69.0 Pneumonitis due to food and vomit	0.001	0.999	0.000
K04.9 Other and unspecified diseases of pulp and periapical tissues	0.000	0.999	0.001
X50.2 School, other institution and public administrative area	0.001	0.999	0.000
X51.8 Other specified place	0.001	0.999	0.000
Z74.1 Need for assistance with personal care	0.000	0.999	0.001
M62.85 Other specified disorders of muscle (Pelvic region and thigh)	0.000	0.999	0.001
M87.27 Osteonecrosis due to previous trauma (Ankle and foot)	0.000	0.999	0.001
F12.9 Unspecified mental and behavioural disorder	0.001	0.999	0.000
F12.8 Other mental and behavioural disorders	0.001	0.999	0.000
F12.7 Residual and late-onset psychotic disorder	0.001	0.999	0.000
F12.6 Amnesic syndrome	0.001	0.999	0.000
F12.4 Withdrawal state with delirium	0.001	0.999	0.000
F12.3 Withdrawal state	0.001	0.999	0.000
F64.0 Transsexualism	0.001	0.999	0.000
H11.0 Pterygium	0.000	0.999	0.001
H81.9 Disorder of vestibular function, unspecified	0.000	0.999	0.001
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.000	0.999	0.001
C71.2 Temporal lobe	0.001	0.999	0.000
H81.8 Other disorders of vestibular function	0.000	0.999	0.001
H81.4 Vertigo of central origin	0.000	0.999	0.001
Z74.8 Other problems related to care-provider dependency	0.000	0.999	0.001
H15.1 Episcleritis	0.001	0.999	0.000
H66.1 Chronic tubotympanic suppurative otitis media	0.001	0.999	0.000
F19 Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances	0.001	0.999	0.000
L53.3 Other chronic figurate erythema	0.000	0.999	0.001
L53.2 Erythema marginatum	0.000	0.999	0.001
L53.1 Erythema annulare centrifugum	0.000	0.999	0.001
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.999	0.001
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.001	0.999	0.000
S52.21 Fracture of shaft of ulna (open)	0.001	0.999	0.000
D84.9 Immunodeficiency, unspecified	0.000	0.999	0.001
F12.5 Psychotic disorder	0.001	0.999	0.000
F19.2 Dependence syndrome	0.001	0.999	0.000
H16.1 Other superficial keratitis without conjunctivitis	0.001	0.999	0.000
H20.8 Other iridocyclitis	0.001	0.999	0.000
H47.5 Disorders of other visual pathways	0.000	0.999	0.001
H15.8 Other disorders of sclera	0.001	0.999	0.000
K85.1 Biliary acute pancreatitis	0.001	0.999	0.000
Q76.0 Spina bifida occulta	0.001	0.999	0.000
T18.9 Foreign body in alimentary tract, part unspecified	0.000	0.999	0.001
F30 Manic episode	0.001	0.999	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.000	0.999	0.001
S32.00 Fracture of lumbar vertebra (closed)	0.000	0.999	0.001
F06.6 Organic emotionally labile [asthenic] disorder	0.001	0.999	0.000
F06.5 Organic dissociative disorder	0.001	0.999	0.000
F06.4 Organic anxiety disorder	0.001	0.999	0.000
F06.1 Organic catatonic disorder	0.001	0.999	0.000
F06.0 Organic hallucinosis	0.001	0.999	0.000
F30.9 Manic episode, unspecified	0.001	0.999	0.000
H06.2 Dysthyroid exophthalmos	0.000	0.999	0.001
M95.0 Acquired deformity of nose	0.001	0.999	0.000
O44.1 Placenta praevia with haemorrhage	0.000	0.999	0.001
X50.9 Unspecified place	0.001	0.999	0.000
X50.8 Other specified place	0.001	0.999	0.000
X50.5 Trade and service area	0.001	0.999	0.000
X50.3 Sports and athletics area	0.001	0.999	0.000
X50.0 Home	0.001	0.999	0.000
X50.7 Farm	0.001	0.999	0.000
X50.1 Residential institution	0.001	0.999	0.000
Z74.3 Need for continuous supervision	0.000	0.999	0.001
W60 Contact with plant thorns and spines and sharp leaves	0.000	0.999	0.001
C67.4 Posterior wall of bladder	0.001	0.999	0.000
C71.5 Cerebral ventricle	0.001	0.999	0.000
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.001	0.999	0.000
K35.2 Acute appendicitis with generalized peritonitis	0.000	0.999	0.001
Z97 Presence of other devices	0.001	0.999	0.000
M79.83 Other specified soft tissue disorders (Forearm)	0.000	0.999	0.001
H16.9 Keratitis, unspecified	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations